Organ support & nutrition

Tidal volume and mortality during extracorporeal membrane oxygenation for acute respiratory distress syndrome: a multicenter observational cohort study

Ann Intensive CarePublished Retrospective multicentre observational cohort study

Authors' conclusion

Mortality predictors change during the course of an ECMO run. In a cohort with high mortality, on day 14 of ECMO support for ARDS, tidal volume may be an independent predictor of mortality.

Study context

Population
Patients with COVID-19 acute respiratory distress syndrome (ARDS) receiving extracorporeal membrane oxygenation (ECMO) in 29 German centres, January 2020–July 2021
Participants
1,137 patients · 29 German centres
Exposure
Day-by-day predictors of mortality during the first 14 days of ECMO
Outcome
All-cause ICU mortality
Methodological detailsmultivariable stepwise logistic regression, retrospectively registered
  • Multivariable stepwise logistic regression
  • Retrospectively registered

Main finding

As reported in the abstract

ICU mortality in the cohort

75%

Observational data: associations, not effects.

Further findings

OutcomeaOR (95% CI)P value
Tidal volume on ECMO day 14 (per 1 mL/kg predicted body weight increase) and mortalityIndependently associated with mortality0.693 (0.564–0.851)P < 0.001
Tidal volume on ECMO day 14 (per 1 mL/kg predicted body weight increase) and mortality — Adjusted mortality with tidal volume below 2 mL/kg on day 14 above
80% (lower limit of the 95% CI)

Predictors on ECMO day 1

Only age and lactate remained in the final mortality prediction model

Mortality of patients still ECMO-dependent on day 14

Comparable to all patients receiving ECMO on day 1

Original publication

Tidal volume and mortality during extracorporeal membrane oxygenation for acute respiratory distress syndrome: a multicenter observational cohort study. Ann Intensive Care. Published 6 October 2025. doi:10.1186/s13613-025-01538-9

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.